Vanguard Group Portfolio holdings
Vanguard Group is an investment manager owned by the funds it manages, and so by its own customers. John Bogle founded it in 1975 and is credited with creating the first index fund available to individual investors. After Wellington Management fired Bogle in 1974, he started a new fund division there and named it Vanguard after HMS Vanguard, Horatio Nelson's flagship. Bogle set up its first index fund in 1976, the fund that became the Vanguard 500 Index Fund, and the firm added a bond index fund in 1986. It began offering ETFs in 2001 as exchange-traded shares of its index funds, and it also serves employers' retirement plans and independent financial advisers. Salim Ramji, who came from BlackRock, was named chief executive in 2024 as the first outsider to lead the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
Sezzle
SEZL
$5.04B
| $75.5M | ﹤0.01% |
1,188,883
+172,115
| +17% | +$11.7M |
2024 Q1
7 quarters
|
|
1977
Atlas Energy Solutions
AESI
$671M
| $75.4M | ﹤0.01% |
8,008,272
+215,243
| +3% | +$2.18M |
2023 Q1
11 quarters
|
|
1978
Bristow Group
VTOL
$1.11B
| $75.3M | ﹤0.01% |
2,056,599
+71,638
| +4% | +$2.7M |
2013 Q2
50 quarters
|
|
|
WSR
1979
DELISTED
Whitestone REIT
WSR
| $75.2M | ﹤0.01% |
5,416,634
+166,306
| +3% | +$2.14M |
2013 Q2
50 quarters
|
|
1980
AnaptysBio
ANAB
$1.43B
| $74.9M | ﹤0.01% |
1,544,037
+67,048
| +5% | +$2.61M |
2017 Q1
35 quarters
|
|
1981
DELISTED
BioLife Solutions
BLFS
| $74.7M | ﹤0.01% |
3,087,386
+119,868
| +4% | +$3.14M |
2015 Q1
43 quarters
|
|
1982
Unitil
UTL
$1.04B
| $74.5M | ﹤0.01% |
1,538,652
+67,456
| +5% | +$3.28M |
2013 Q2
50 quarters
|
|
1983
Oruka Therapeutics
ORKA
$6.92B
| $74.4M | ﹤0.01% |
2,453,530
+676,865
| +38% | +$18.9M |
2020 Q3
21 quarters
|
|
1984
Endeavour Silver
EXK
$2.39B
| $74.3M | ﹤0.01% |
7,899,506
+3,594,123
| +83% | +$30.5M |
2024 Q2
6 quarters
|
|
1985
Iovance Biotherapeutics
IOVA
$3.74B
| $74.3M | ﹤0.01% |
27,207,079
+3,148,096
| +13% | +$7.28M |
2015 Q1
43 quarters
|
|
1986
Bausch Health
BHC
$3.1B
| $74.1M | ﹤0.01% |
10,679,760
-1,561,312
| -13% | -$10.3M |
2015 Q1
43 quarters
|
|
1987
Capricor Therapeutics
CAPR
$516M
| $73.9M | ﹤0.01% |
2,561,880
+355,161
| +16% | +$4.64M |
2015 Q2
42 quarters
|
|
1988
NexPoint Residential Trust
NXRT
$403M
| $73.3M | ﹤0.01% |
2,436,034
+70,310
| +3% | +$2.15M |
2015 Q2
42 quarters
|
|
1989
N-able
NABL
$850M
| $73.1M | ﹤0.01% |
9,779,211
-295,751
| -3% | -$2.26M |
2021 Q3
17 quarters
|
|
1990
Taysha Gene Therapies
TSHA
$1.39B
| $73M | ﹤0.01% |
13,267,805
+418,192
| +3% | +$2.03M |
2020 Q3
21 quarters
|
|
1991
Bank First Corp
BFC
$1.67B
| $72.9M | ﹤0.01% |
598,817
+10,052
| +2% | +$1.28M |
2019 Q2
26 quarters
|
|
1992
Ero Copper
ERO
$3.2B
| $72.1M | ﹤0.01% |
2,546,856
+1,112,428
| +78% | +$25.9M |
2021 Q2
18 quarters
|
|
1993
USA Rare Earth Inc
USAR
$2.97B
| $71.8M | ﹤0.01% |
6,036,486
+5,083,288
| +533% | +$96.8M |
2025 Q2
2 quarters
|
|
1994
JOYY Inc
JOYY
$3.99B
| $71.6M | ﹤0.01% |
1,105,027
+5,970
| +0.5% | +$365K |
2015 Q4
40 quarters
|
|
1995
Adtran
ADTN
$359M
| $71.2M | ﹤0.01% |
8,188,496
-194,809
| -2% | -$1.69M |
2013 Q2
50 quarters
|
|
1996
Ameresco
AMRC
$1.19B
| $70.7M | ﹤0.01% |
2,414,838
+2,478
| +0.1% | +$87K |
2013 Q2
50 quarters
|
|
1997
Dr. Reddy's Laboratories
RDY
$12.4B
| $70.6M | ﹤0.01% |
5,027,272
-96,437
| -2% | -$1.35M |
2013 Q2
50 quarters
|
|
1998
Middlesex Water
MSEX
$1.14B
| $70.5M | ﹤0.01% |
1,398,851
+25,363
| +2% | +$1.36M |
2013 Q2
50 quarters
|
|
1999
Orchid Island Capital
ORC
$946M
| $70.3M | ﹤0.01% |
9,767,670
+1,850,221
| +23% | +$13.5M |
2013 Q2
50 quarters
|
|
2000
Maze Therapeutics
MAZE
$1.94B
| $70.3M | ﹤0.01% |
1,697,015
+362,060
| +27% | +$12.4M |
2025 Q1
3 quarters
|
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.